In cancer cells, Sox9 and Krüppel-like factor 4 (KLF4) interact with β-catenin and reduce its binding to TCF4 [34] and showed anti-oncogenic activity by inhibiting the activity of the Wnt/β-catenin signaling pathway [35]. The gene discussed is SOX9; the disease is cancer.